ASP Isotopes Files 8-K for Regulation FD Disclosure

TL;DR

ASP Isotopes filed an 8-K for a Reg FD disclosure, no new material info.

AI Summary

ASP Isotopes Inc. filed an 8-K on August 25, 2025, to report a Regulation FD Disclosure. The filing does not contain specific financial figures or material events beyond the disclosure itself.

Why It Matters

This filing indicates ASP Isotopes Inc. is making a public disclosure under Regulation FD, ensuring all investors receive the same material information simultaneously.

Risk Assessment

Risk Level: low — The filing is a standard procedural disclosure and does not indicate any new risks or material changes to the company's operations or financial status.

Key Players & Entities

• ASP Isotopes Inc. (company) — Registrant
• August 25, 2025 (date) — Date of earliest event reported
• Regulation FD (regulation) — Type of disclosure

FAQ

Key Financial Figures

• $0.01 — ich registered Common Stock, par value $0.01 ASPI The Nasdaq Stock Market LLC

Filing Documents

• aspi_8k.htm (8-K) — 39KB
• 0001477932-25-006215.txt ( ) — 163KB
• aspi-20250825.xsd (EX-101.SCH) — 5KB
• aspi-20250825_lab.xml (EX-101.LAB) — 15KB
• aspi-20250825_cal.xml (EX-101.CAL) — 1KB
• aspi-20250825_pre.xml (EX-101.PRE) — 10KB
• aspi-20250825_def.xml (EX-101.DEF) — 2KB
• aspi_8k_htm.xml (XML) — 4KB

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. ASP Isotopes Inc. (the "Company") will host a corporate access event on August 26, 2025 for South African investors in advance of the anticipated secondary listing of ASP Isotopes on the Johannesburg Stock Exchange (JSE). The listing of the Company's common stock on the Main Board of the JSE and the commencement of trading is expected to take effect on August 27, 2025. The secondary listing on the JSE is not in connection with any current capital raising effort and the Company will retain its primary listing on the Nasdaq Capital Market. During the investor access event the Company will provide several updates on the progress of commercial production at the Company's three isotope enrichment facilities in Pretoria, South Africa, as well as other corporate matters. Silicon-28 . The Company commenced commercial production of Silicon-28 during late March 2025. During August 2025, the Company shipped its first samples of enriched Silicon-28 to a customer in the United States. Many researchers believe that highly enriched Silicon-28 will be required by manufacturers of next-generation semiconductors. Naturally occurring Silicon has three isotopes – 28, 29 and 30. The 29 isotope has a positive spin, which is an intrinsic form of angular momentum carried by elementary particles. In contrast, highly enriched Silicon-28 is spin-free where qubits are protected from sources of decoherence that causes loss of quantum information. In addition to its potential to process superior information such as qubits, it is believed that highly enriched Silicon-28 can conduct heat 150% more efficiently than natural Silicon, which will potentially allow for chips to become smaller, faster and cooler. Ytterbium-176 . The Company commenced commercial production of Ytterbium-176 during April 2025 and has successfully enriched significant quantities of intermediate product to as high as 92.4%. The Company is currently achieving an enrichment factor of

Forward Looking Statements

Forward Looking Statements This Form 8-K contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations, and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. Forward-looking statements can be identified by words such as "goal", "target", "believes," "plans," "anticipates," "expects," "aims", "intends", "estimates," "projects," "will," "may," "might," "seeks", "sees", "should," "would," "expect," "positioned," "strategy," and words of a similar nature. Examples of forward-looking statements include, among others but are not limited to, statements relating to the commencement of supply of isotopes to customers, the construction of additional enrichment facilities, the completion of the Renergen acquisition and other transactions in the anticipated timeframe or at all, the plans for a spin-out of Quantum Leap Energy as a standalone public company, and statements we make regarding expected operating results, such as future revenues and prospects from the potential commercialization of isotopes, future performance under contracts, and our strategies for product development, engaging with potential customers, market position, and financial results. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict, many of which are outside our control. Our actual results, financial condition, and events may differ materially from those indicated in the forward-looking statements based upon a number of factors. Forward-looking statements are not a guarantee of future performance or developments. You are strongly caut

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ASP ISOTOPES INC. Date: August 25, 2025 By: /s/ Donald G. Ainscow Name: Donald G. Ainscow Title: Executive Vice President, General Counsel and Secretary 4

View Full Filing

View this 8-K filing on SEC EDGAR